Thakkar N, Osama M, Dhawan S
Indian J Surg Oncol. 2024; 15(4):789-795.
PMID: 39555351
PMC: 11564589.
DOI: 10.1007/s13193-024-01997-9.
Gupta G, Jamwal N, Gupta R
BMC Public Health. 2024; 24(1):2087.
PMID: 39090665
PMC: 11295321.
DOI: 10.1186/s12889-024-19622-3.
Das U, Soren S, Kar N
Arch Public Health. 2024; 82(1):55.
PMID: 38654339
PMC: 11041000.
DOI: 10.1186/s13690-024-01266-9.
Roy P
J Cancer Res Clin Oncol. 2023; 149(15):14409-14427.
PMID: 37552309
DOI: 10.1007/s00432-023-05215-x.
Mehrotra R, Yadav K
World J Clin Oncol. 2022; 13(3):209-218.
PMID: 35433294
PMC: 8966510.
DOI: 10.5306/wjco.v13.i3.209.
Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.
ElBiad O, Laraqui A, El Boukhrissi F, Mounjid C, Lamsisi M, Bajjou T
BMC Cancer. 2022; 22(1):208.
PMID: 35216584
PMC: 8876448.
DOI: 10.1186/s12885-022-09181-4.
/ mutation spectrum analysis in South Asia: a systematic review.
Kharel S, Shrestha S, Yadav S, Shakya P, Baidya S, Hirachan S
J Int Med Res. 2022; 50(1):3000605211070757.
PMID: 35000471
PMC: 8753086.
DOI: 10.1177/03000605211070757.
Mutation in Exon2 of BRCA1 Gene in Adult Bengali Bangladeshi Female Patients with Breast Cancer: An Experience from Two Tertiary-Care Hospitals.
Chowdhury S, Khatun M, Khan T, Laila A
Asian Pac J Cancer Prev. 2020; 21(8):2265-2270.
PMID: 32856854
PMC: 7771933.
DOI: 10.31557/APJCP.2020.21.8.2265.
Impact of p53 arg72pro SNP on Breast Cancer Risk in North Indian Population.
Akhter N, Dar S, Chattopadhyay S, Haque S, Anwer R, Wahid M
Curr Genomics. 2018; 19(5):395-410.
PMID: 30065615
PMC: 6030857.
DOI: 10.2174/1389202919666171205104137.
Mutations in context: implications of BRCA testing in diverse populations.
Felix G, Zheng Y, Olopade O
Fam Cancer. 2017; 17(4):471-483.
PMID: 28918466
PMC: 5980658.
DOI: 10.1007/s10689-017-0038-2.
Treatment Challenges and Survival Analysis of Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Real World.
Adusumilli P, Konatam M, Gundeti S, Bala S, Maddali L
Indian J Med Paediatr Oncol. 2017; 38(1):22-27.
PMID: 28469333
PMC: 5398102.
DOI: 10.4103/0971-5851.203511.
Proteomic Analysis of Stage-II Breast Cancer from Formalin-Fixed Paraffin-Embedded Tissues.
Al-Dhabi N, Srigopalram S, Ilavenil S, Kim Y, Agastian P, Baaru R
Biomed Res Int. 2016; 2016:3071013.
PMID: 27110560
PMC: 4823502.
DOI: 10.1155/2016/3071013.
Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India.
Mannan A, Singh J, Lakshmikeshava R, Thota N, Singh S, Sowmya T
J Hum Genet. 2016; 61(6):515-22.
PMID: 26911350
DOI: 10.1038/jhg.2016.4.
Minor role of BRCA2 mutation (Exon2 and Exon11) in patients with early-onset breast cancer amongst Iranian Azeri-Turkish women.
Karimian Fathi N, Shekari Khaniani M, Montazeri V, Mansoori Derakhshan S
Iran J Basic Med Sci. 2014; 17(2):108-11.
PMID: 24711893
PMC: 3976747.
Identification of novel splice variants and exons of human endothelial cell-specific chemotaxic regulator (ECSCR) by bioinformatics analysis.
Lu J, Li C, Shi C, Balducci J, Huang H, Ji H
Comput Biol Chem. 2012; 41:41-50.
PMID: 23147565
PMC: 3513626.
DOI: 10.1016/j.compbiolchem.2012.10.003.
BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity.
Juwle A, Saranath D
Med Oncol. 2012; 29(5):3272-81.
PMID: 22752604
DOI: 10.1007/s12032-012-0294-9.
BRCA1 and BRCA1 Genes and Inherited Breast and/or Ovarian Cancer: Benefits of Genetic Testing.
Somasundaram K
Indian J Surg Oncol. 2012; 1(3):245-9.
PMID: 22693372
PMC: 3244237.
DOI: 10.1007/s13193-011-0049-7.
Breast Cancer Care in India: The Current Scenario and the Challenges for the Future.
Agarwal G, Ramakant P
Breast Care (Basel). 2010; 3(1):21-27.
PMID: 20824016
PMC: 2931014.
DOI: 10.1159/000115288.
Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.--a SEER analysis.
Kakarala M, Rozek L, Cote M, Liyanage S, Brenner D
BMC Cancer. 2010; 10:191.
PMID: 20459777
PMC: 2873947.
DOI: 10.1186/1471-2407-10-191.
Organization and running of the first comprehensive hereditary cancer clinic in India.
Rajkumar T, Soumittra N, Vidubala E, Sridevi V, Mahajan V, Ramanan S
Hered Cancer Clin Pract. 2010; 3(4):165-70.
PMID: 20223043
PMC: 2837059.
DOI: 10.1186/1897-4287-3-4-165.